All filters
Slidesets
Abstract: Prevalence of neuropsychiatric conditions among HIV positive compared to HIV negative commercially insured individuals in 2017 NAFLD with dyslipidemia (#5) | Joshua Cohen, PhD
Presented at:
HIV DART and Emerging Viruses 2018
Slidesets
Abstract: Darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in a rapid initiation model of care for HIV-1 infection: Week 24 interim analysis of the DIAMOND study (#6) | Keith Dunn, PharmD, BCPS, AAHIVE
Presented at:
HIV DART and Emerging Viruses 2018
Slidesets
Abstract: Initial viral load decline and response rates by baseline viral load strata with dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate/emtricitabine: Pooled results from the GEMINI studies (#7) | Michael Aboud
Presented at:
HIV DART and Emerging Viruses 2018
Slidesets
Hispanic/Latino longitudinal cohort of HIV-seropositive women and neurological complications | Loyda Melendez, PhD
Presented at:
HIV DART and Emerging Viruses 2018
Slidesets
Abstract: Rhesus macaque model of SIV/SHIV-Zika co-infection (#9) | Siddappa Byrareddy
Presented at:
HIV DART and Emerging Viruses 2018
Slidesets
Development of protease inhibitors against norovirus and other emerging viruses | Ladislau Kovari
Presented at:
HIV DART and Emerging Viruses 2018
Slidesets
Presentation of Gertrude Elion Distinguished Lecturer Award recipient | Rowena Johnston, PhD
Presented at:
HIV DART and Emerging Viruses 2018
Slidesets
Opening remarks and presentation of Gertrude Elion Distinguished Lecturer Award | Raymond Schinazi, PhD, DSc
Presented at:
HIV DART and Emerging Viruses 2018
Slidesets
State of the Art Lecture: Molecular basis for HIV latency | Jonathan Karn, PhD
Presented at:
HIV DART and Emerging Viruses 2018
Slidesets
Understanding barriers to HIV cure | Robert Siliciano, MD, PhD
Presented at:
HIV DART and Emerging Viruses 2018
Slidesets
Gertrude Elion Distinguished Lecturer Award Lecture: Innovation with an Impact: Development of HIV and TB drugs | Paul Stoffels, MD
Presented at:
HIV DART and Emerging Viruses 2018
Slidesets
HIV reservoir dynamics: Implications for HIV latency establishment and reversal | Deanna Kulpa, PhD
Presented at:
HIV DART and Emerging Viruses 2018
Slidesets
Baricitinib reverses HIV associated neurocognitive disorders and reservoir seeding in a SCID mouse model | Christina Gavegnano, PhD
Presented at:
HIV DART and Emerging Viruses 2018
Slidesets
State of the Art Lecture: Harnessing the immune system to eliminate and/or control HIV | Steven Deeks, MD
Presented at:
HIV DART and Emerging Viruses 2018
Slidesets
Potential for HIV cure by stem cell transplantation (IciStem) | Monique Nijhuis, PhD
Presented at:
HIV DART and Emerging Viruses 2018
Slidesets
Abstract: Differential detection of M184V/I between plasma historical HIV genotypes and proviral DNA from PBMCs (#3) | Nicolas Margot
Presented at:
HIV DART and Emerging Viruses 2018
Slidesets
Abstract: Oral ABX464 has a dose dependent reduction in the HIV-1 DNA reservoir in CD4+ Peripheral Blood T Cells (#2) | Jean-Marc Steens
Presented at:
HIV DART and Emerging Viruses 2018
Slidesets
Presentation of Barry-Wainberg DART Achievement Award and recipient | Charles Boucher, MD, PhD
Presented at:
HIV DART and Emerging Viruses 2018
Slidesets
State of the Art Lecture: Rational design of doravirine (DOR): From bench to patients | Daria Hazuda, PhD
Presented at:
HIV DART and Emerging Viruses 2018
Slidesets
Injectable ART: Advantages and disadvantages | Michael Saag, MD
Presented at:
HIV DART and Emerging Viruses 2018
Slidesets
A post-transcriptional feedback mechanism for noise suppression and fate stabilization | Leor Weinberger, PhD
Presented at:
HIV DART and Emerging Viruses 2018
Slidesets
Barry-Wainberg DART Achievement Award Lecture: Overview of the research conducted at the Irsicaixa Foundation | Bonaventura Clotet, MD, PhD
Presented at:
HIV DART and Emerging Viruses 2018